ImmuCell Corporation (ICCC) issued a press release on July 9, 2026, reporting a preliminary 11.5% increase in product sales for Q2 2026 compared to Q2 2025, based on unaudited results for the quarter ended June 30, 2026. The press release is filed as Exhibit 99.1 to this 8-K.
View Full Filing (SEC EDGAR)Immucell CORP
+$791.8K
Net Activity
Institutions Holding
27
Popularity Rank
#7553
Avg Weight
0.01%
Total Value
$8.7M
Ownership Trend
27 institutions currently hold ICCC, with 9 net buyers and 7 net sellers this quarter.
Institutional Moves
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
7
Net Buying Institutions
9
Key Holders
Key Holders
Top 5 by Value
Quarterly Activity
Recent Activity
+$3.6M
Total Buy Value
$1.3M
Total Sell Value
9
Net Buyers
7
Net Sellers
Insider Trading (Form 4)
Form 144 Pre-Sale Notices
No Form 144 planned sale filings in the last 90 days
Beneficial Ownership (13D/13G)
No Schedule 13D/13G filings for this ticker
Material Events (8-K)
FAQ
Who are the top institutional investors holding IMMUCELL CORP (ICCC)?
What is the overall institutional sentiment toward ICCC recently?
Which institutions have been selling or reducing their ICCC positions?
Are there any notable investors adding ICCC to their portfolios?
Related Stocks
Trending Institutional Adds
The most-added stocks by 13F institutions this quarter
Microsoft CORP
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Amazon.com INC
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Nvidia CORP
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter